COVID-19 Infection

Tianjin First Central Hospital

Status: Not yet enrolling

Conditions: COVID-19; Renal Transplant Infection

Treatments: Other: Treatment plan

Study type: Observational

Funder types: Other

Identifiers

NCT05926076

2023-036-02

Details and patient eligibility

About

Post-transplant patients with COVID-19 infection who attended Shenzhen No. 3 Hospital from December 2022 to February 2023, and enrolled the general population with COVID-19 infection who were hospitalized during the same period, matched by age and gender.

Full description

Data collection：Age, BMI, underlying comorbidities and other basic information were collected retrospectively from the two groups. The medical records were used to collect information about the patients' new coronavirus infection, such as the time of onset of symptoms, time of diagnosis, time of conversion and common symptoms such as fever, cough, nasal congestion and runny nose, muscle aches and pains.To compare the differences of the diagnosis and treatment of KTRs and the general population infected with Omicron

Enrollment: 610 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Confirmed novel coronavirus infection between December 2022 to February 2023,

Exclusion criteria

Age less than 18; failure of the transplanted kidney before the new coronavirus infection; exclusion of oral immunosuppressed and other types of organ transplant recipients from the non-renal transplant population

Trial design

610 participants in 2 patient groups

Kidney Transplant Recipients Group (KTR)

Treatment:

Other: Treatment plan

Non-Kidney Transplant Recipients Group（NKTR）

Treatment:

Other: Treatment plan